Selected recent publications:

• Nasr J, Malik S, DeVera M, Tom K, Fontes P, Marcos A, Ahmad J. Pre-transplant transjugular portosystemic shunt does not adversely affect outcome after orthotopic liver transplantation. American Transplant Congress, American Journal of Transplantation 2008 (8):375.
• DeVera M, Tom K, Lopez R, Patel S, Fontes P, Marsh W, Marcos A, Dvorchik I. Acute renal failure after liver transplantation: donor and recipient associated risk factors. American Transplant Congress, American Journal of Transplantation 2008 (8):467
• Dvorchik I, Fontes P, Tom K, Lopez R, Sharma V, Marsh W, Marcos A, DeVera M. Prognostic factors of acute renal failure early after liver transplantation. American Transplant Congress, American Journal of Transplantation 2008 (8):377.
• Mavrakis A, Malik S, DeVera M, Tom K, Fontes P, Marcos A, Ahmad J. Risk factors for poor outcome after liver transplantation in obese patients. American Transplant Congress, American Journal of Transplantation 2008 (8):375.
• Xiao G, Tai S, Fontes P, Gamblin C, Geller D, Marsh JW, Nalesnik M, Carr B, DeVera M. Systemic adjuvant chemotherapy for stage III or IV hepatocellular carcinoma post liver transplantation improves survival. Liver Transplantation 2007 (13):192.
• Tan H, Tom K, Thai N, Fontes P, DeVera M, Sharma V, Donaldson J, Dvorchik I, Starzl TE, Marcos A. Living donor liver transplantation under Alemtuzumab pre-conditioning and Tacrolimus monotherapy: two-year outcomes. Liver Transplantation 2007 (13):185.
• Kayler L, Tom K, Fontes P, Dvorchik I, Marcos A. Financial comparison of adult-to-adult liver transplantation from living- vs decased-donors. Liver Transplantation 2007 (13):108.
• Malik S, Sass D, Behari J, Chadalavada R, DeVera M, Fontes P, Marcos A, Demetris AJ, Ahmad J. Outcome of regenerative hyperplasia after liver transplantation. American Journal of Transplantation 2007 (7):474.
• Mohanka R, Kayler L, Tom K, Fontes P, Dvorchik I, DeVera M, Soltys K, Blisard D, Sharma
  V. Financial comparison of adult-to-adult liver transplantation from living -vs deceased-   donors. American Journal of Transplantation 2007 (7):472.
• Daily M, Gamblin C, Marsh W, Geller D, Nalesnink M, Fontes P, Amesur N, Carr B, DeVera M. Use of 90Yttrium microspheres to downstage hepatocelular carcinoma and as a bridge to liver transplantation. American Journal of Transplantation 2007 (7):465.
• Abu-Elmagd K, Costa G, Haider H, Bond G, Wu T, Fontes P, Marsh W, Marcos A, Starzl TE. Evolution of the surgical management of portomesenteric venous thrombosis (PMVT): 25 years of experience at a single center. American Journal of Transplantation 2007 (7):297.
•  Malik S, DeVera M, Chadalavada R, Sass D, Fontes P, Marcos A, Ahmad J. Factots predicting of poor outcome after liver transplantation for NASH. American Journal of Transplantation 2007 (7):242.
• Tan H, Tom K, Tai N, Fontes P, DeVera M, Sharma V, Donaldson J, Dvorchik I, Starzl TE, Marcos A. Living dono liver transplantation under Alemtuzumab pre-conditioning and Tacrolimus monotherapy.  American Journal of Transplantation 2007 (7):214.
• Malik SM, DeVera M, Chadalavada R, Sass D, Fontes P, Marcos A, Ahmad J. Incidence and outcome of recurrent  NASH in liver transplant recipients. American Journal of Transplantation 2007 (7):164.

CONTACT INFORMATION

Paulo Fontes, MD
Phone: (412) 647-7344
Email: fontesp@upmc.edu